Idiopathic pulmonary fibrosis
RecruitingA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
- Disease:Idiopathic pulmonary fibrosis
- Substances:ABBV-142
France- Participants:18–64 years · 65+ years
- Substances:ABBV-142
- Sponsor:AbbVie Deutschland GmbH & Co. KG









